Heska Corp represents values of innovation, integrity, and commitment in the veterinary diagnostic and specialty products industry. The company is dedicated to providing advanced and reliable solutions that improve animal health and the veterinary experience. With a corporate philosophy centered on delivering quality products and exceptional customer service, Heska Corp strives to make a positive impact on the veterinary community and ultimately contribute to the well-being of animals worldwide.

Heska Corp is primarily present in the United States and around the globe. With its headquarters situated in Loveland, Colorado, the company has a strong presence in the domestic market. Additionally, Heska Corp has expanded its reach to various international markets, catering to the needs of veterinarians and animal healthcare providers worldwide. With its innovative and high-quality veterinary products and solutions, Heska Corp has gained recognition in countries and regions across North America, Europe, Asia, and Latin America. As a leading player in the veterinary diagnostics and specialty products industry, Heska Corp continues to serve its customers globally with its extensive network and strategic partnerships.

Heska Corp has achieved several significant milestones throughout its history. One notable milestone was in 2001, when Heska became a publicly traded company on the NASDAQ stock exchange, marking a major step in its growth and development. Additionally, in 2015, Heska Corp introduced the Element COAG Veterinary Hemostasis Analyzer, a groundbreaking diagnostic instrument that revolutionized coagulation testing in veterinary medicine. Furthermore, in 2018, Heska acquired CVM Diagnostico Veterinario, a leading veterinary diagnostic company in Latin America, expanding its global presence and market reach. These milestones demonstrate Heska Corp's commitment to innovation, expansion, and providing advanced diagnostic solutions for the veterinary industry.

Heska Corp is a leading animal health company founded in 1988. With headquarters in Loveland, Colorado, it has become a prominent player in veterinary diagnostics, vaccines, and specialty products. Heska Corp operates in four main segments: Core Companion Animal Health, including point-of-care diagnostic instruments; Other Vaccines and Pharmaceuticals, providing pharmaceuticals and vaccines for pets; North American Production Animal, focusing on advanced solutions for livestock management; and International, catering to veterinary needs worldwide. Heska Corp's commitment to innovation and quality has earned it a solid reputation in the veterinary industry, making it a trusted partner for pet owners, veterinarians, and livestock producers globally.

The main competitors of Heska Corp in the market include IDEXX Laboratories, Abaxis Inc., and Zoetis Inc. These companies operate in the animal health and veterinary diagnostics sector, similar to Heska Corp. IDEXX Laboratories is a key competitor known for its broad range of diagnostic products and services. Abaxis Inc., now a part of Zoetis Inc., also offers a variety of diagnostic instruments and consumables for animal healthcare. These competitors challenge Heska Corp by providing alternative solutions and vying for market share in the veterinary diagnostics industry.

Heska Corp is primarily active in the animal health industry.

The business model of Heska Corp revolves around providing advanced veterinary diagnostic and specialty products. Heska specializes in developing and manufacturing veterinary laboratory instruments, consumables, and software solutions. The company aims to improve pet care by offering innovative point-of-care diagnostics, digital imaging tools, and specialized tests to veterinary professionals worldwide. Heska's products enable veterinarians to make faster and more accurate diagnoses, resulting in improved treatment and care for animals. With its commitment to technological advancements and focus on veterinary diagnostics, Heska Corp strives to enhance the overall well-being of pets and strengthen the veterinary industry.

สัดส่วนราคาต่อกำไรของ Heska คือ 811.29

KUV ของ Heska คือ 3.61

AlleAktien คุณภาพสกอร์สำหรับ Heska คือ 4/10.

คาดหวัง Heska มียอดขายอยู่ที่ 343.42 ล้าน USD

กำไร คาดหวัง Heska คือ 1.53 ล้าน USD

The Heska Corporation is a leading company in the animal health industry, offering innovative diagnostic and therapeutic solutions to veterinarians and pet owners. The company, headquartered in Loveland, Colorado, was founded in 1988 and now has subsidiaries in the USA, Europe, and Asia. Heska offers a wide range of products and services for animal health, divided into three divisions: 1. Diagnostics: Heska's diagnostics division provides veterinarians with a wide range of tests, instruments, and systems for diagnosing diseases in animals. The product range includes simple rapid tests for routine examinations to specialized devices for complex diagnoses. Products include blood tests for dogs and cats, in-house diagnostic devices, analyzers for laboratory testing, and diagnostic systems for infectious diseases. 2. Scientific research: Heska has a strong presence in scientific research, particularly in immunology and oncology. The company offers a wide range of research products and services, including antibodies, enzymes, kits, and test systems for in vitro research. Heska has long-standing partnerships with renowned scientists and institutes around the world. 3. Therapeutics: Heska's therapeutics division focuses on the development and marketing of drugs and therapies for animals. The company has a wide range of products on the market, including pain relievers, antibiotics, and immunomodulators. Heska works closely with veterinarians and pet owners to ensure that its products meet the needs of animals and are effective. Heska is committed to offering innovative solutions for animal health and investing continuously in research and development. The company has a strong presence in the market and is known for its high-quality products and services. Heska also has a strong online presence and offers training and support for veterinarians and pet owners through its web portal. In summary, Heska offers a wide range of products and services for animal health. The company specializes in diagnostics, research, and therapeutics and is known for its high quality and innovation. Heska is committed to improving the health and well-being of animals worldwide and works closely with veterinarians and pet owners to ensure that its products meet the needs of animals.

Heska จ่ายเงินปันผล 0 USD ผ่าน ครั้งในหนภายในหนึ่งปี.

ปัจจุบันไม่สามารถคำนวณเงินปันผลสำหรับ Heska หรือบริษัทไม่จ่ายเงินปันผล.

ISIN ของ Heska คือ US42805E3062

WKN ของ Heska คือ A1H5J3.

ตัวย่อของ Heska คือ HSKA

ภายในช่วง 12 เดือนที่ผ่านมา Heska จ่ายเงินปันผลทั้งหมด 0.3 USD นี้เทียบเท่ากับอัตราผลตอบแทนจากเงินปันผลประมาณ 0.25 % สำหรับ 12 เดือนข้างหน้า Heska คาดว่าจะจ่ายเงินปันผลทั้งหมด 2.88 USD

อัตราผลตอบแทนเงินปันผลของ Heska ในปัจจุบันคือ 0.25 %

Heska จ่ายเงินปันผลทุกไตรมาส การจ่ายเงินปันผลจะเกิดขึ้นในเดือน

Heska จ่ายเงินปันผลทุกปีในช่วง 6 ปีที่ผ่านมา.

คาดว่าในช่วง 12 เดือนข้างหน้าจะมีการจ่ายเงินปันผลทั้งหมด 2.88 USD ซึ่งเทียบเท่ากับผลตอบแทนจากเงินปันผลร้อยละ 2.4 %

Heska ถูกจัดให้อยู่ในภาคส่วน 'สุขภาพ'

เพื่อรับเงินปันผลล่าสุดของ Heska ในวันที่ 10/10/2555 ที่มูลค่า 0.1 USD คุณจะต้องถือหุ้นไว้ในพอร์ตก่อนวันที่เป็น Ex-Tag ในวันที่ 26/9/2555

การจ่ายเงินปันผลครั้งล่าสุดเกิดขึ้นเมื่อวันที่ 10/10/2555

ในปี 2024 บริษัท Heska ได้จ่ายเงินปันผลเป็นจำนวน 0 USD

เงินปันผลของ Heska จะถูกจ่ายใน USD